“Investment will flow towards digital solutions to augment treatment”

In 2017, Dr Ruchir Mehra, Harsh V Bansal, and Richeek Arya, came together and started Remedo as a digital engagement platform to help doctors effectively manage their patients with chronic diseases, providing end-to-end care in their recovery process.

- Narayan Kulkarni

Remedo has partnered with the leading Indian pharma companies to offer its telemedicine services to more than 3000 doctors across specialties. In three years of its inception, it has already helped more than 1 lakh patients by connecting expert doctors with chronically ill patients, even in remotely connected areas of the country. By using the program, doctors have witnessed a 17 per cent increase in follow-up visits and 80 per cent reorder rate for medicines in a span of 4 to 5 months.

Telemedicine has become crucial amidst the ongoing crisis caused by COVID-19 and the government initiatives have helped Remedo reach to the maximum share of patients. Social distancing and remote consultations are now the future of the health tech system which makes Remedo a perfect choice for patients and doctors. BioSpectrum spoke Dr Ruchir Mehra, CEO & Co-founder, Remedo, Delhi, India about the challenges faced and growth plans of the company.

What were the challenges faced while setting up the business?